查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2019735

全球動物疫苗市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Animal Vaccines Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

動物疫苗市場預計將從 2025 年的 107.3 億美元成長到 2034 年的 201.5 億美元，2026 年至 2034 年的複合年成長率為 7.26%。

受動物保健產品需求不斷成長以及預防牲畜和伴侶動物感染疾病的迫切需要，全球動物疫苗市場正經歷強勁成長。疫苗接種在確保食品安全、提高動物生產力以及控制通用感染疾病傳播方面發揮著至關重要的作用。畜牧業的擴張和動物健康意識的提高是推動市場成長的主要因素。

關鍵促進因素包括全球對動物性食品需求的成長、獸醫保健投資的增加以及政府推廣疫苗接種計劃的措施。疫苗研發技術的進步，包括重組疫苗和DNA疫苗，提高了疫苗的有效性和安全性。此外，人們疾病預防意識的提高也促進了疫苗接種的廣泛發展。

展望未來，市場有望受益於持續創新和先進疫苗技術的開發。數位化監測工具的整合以及分銷系統的改進將提升疫苗的可及性和有效性。隨著全球對動物健康解決方案的需求持續成長，動物疫苗市場預計將迎來強勁且永續的成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球動物疫苗市場：依動物類型分類

  • 市場分析、洞察與預測
  • 牲畜（家禽、牛、豬、水產養殖、綿羊和山羊）
  • 伴侶動物（狗、貓、馬、鳥）

第5章 全球動物疫苗市場：依疫苗類型分類

  • 市場分析、洞察與預測
  • 減毒活病毒疫苗
  • 結合疫苗
  • 去活化疫苗
  • DNA疫苗
  • 重組疫苗
  • 其他疫苗類型

第6章：全球動物疫苗市場：依應用分類

  • 市場分析、洞察與預測
  • 細菌感染疾病
  • 病毒感染疾病
  • 寄生蟲感染疾病
  • 黴菌感染疾病
  • 其他用途

第7章 全球動物疫苗市場：依給藥途徑分類

  • 市場分析、洞察與預測
  • 注射疫苗
  • 口服疫苗
  • 浸泡式和噴灑式疫苗

第8章：全球動物疫苗市場：依通路分類

  • 市場分析、洞察與預測
  • 獸藥
  • 零售藥房
  • 電子商務

第9章 全球動物疫苗市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Zoetis
    • Merck Animal Health
    • Boehringer Ingelheim
    • Elanco
    • Virbac
    • Ceva Sante Animale
    • Dechra Pharmaceuticals
    • Neogen Corporation
    • Vetoquinol
    • Brilliant Bio Pharma
    • Indian Immunologicals
    • Hipra
    • Henry Schein
    • Bioveta
    • Durvet
簡介目錄
Product Code: VMR11218009

The Animal Vaccines Market size is expected to reach USD 20.15 Billion in 2034 from USD 10.73 Billion (2025) growing at a CAGR of 7.26% during 2026-2034.

The global animal vaccines market is experiencing strong growth due to increasing demand for animal health products and the need to prevent infectious diseases in livestock and companion animals. Vaccination plays a critical role in ensuring food safety, improving animal productivity, and reducing the spread of zoonotic diseases. The expansion of the livestock industry and growing awareness of animal health are key factors driving market growth.

Key drivers include rising global demand for animal-based food products, increasing investments in veterinary healthcare, and government initiatives promoting vaccination programs. Technological advancements in vaccine development, including recombinant and DNA vaccines, are improving efficacy and safety. Additionally, the growing focus on disease prevention is encouraging widespread adoption of vaccination practices.

Looking ahead, the market is expected to benefit from continuous innovation and the development of advanced vaccine technologies. The integration of digital monitoring tools and improved distribution systems will enhance accessibility and effectiveness. As global demand for animal health solutions continues to rise, the animal vaccines market is set for strong and sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Animal Type

  • Livestock Animals (Poultry, Cattle, Swine, Aquaculture, Sheep And Goats)
  • Companion Animals (Canine, Feline, Equine, Avian)

By Vaccine Type

  • Attenuated Live Vaccine
  • Conjugate Vaccine
  • Inactivated Vaccine
  • Dna Vaccine
  • Recombinant Vaccine
  • Other Vaccine Types

By Application

  • Bacterial Infections
  • Viral Infections
  • Parasitic Infections
  • Fungal Infections
  • Other Applications

By Route Of Administration

  • Injection Vaccines
  • Oral Vaccines
  • Immersion/Spray Vaccines

By Distribution Channel

  • Veterinary Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

COMPANIES PROFILED

  • Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Virbac, Ceva Sant Animale, Dechra Pharmaceuticals, Neogen Corporation, Vetoquinol, Brilliant Bio Pharma, Indian Immunologicals, Hipra, Henry Schein, Bioveta, Durvet
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANIMAL VACCINES MARKET: BY ANIMAL TYPE 2022-2034 (USD MN and Million Doses)

  • 4.1. Market Analysis, Insights and Forecast Animal Type
  • 4.2. Livestock Animals (Poultry, Cattle, Swine, Aquaculture, Sheep And Goats) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.3. Companion Animals (Canine, Feline, Equine, Avian) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL ANIMAL VACCINES MARKET: BY VACCINE TYPE 2022-2034 (USD MN and Million Doses)

  • 5.1. Market Analysis, Insights and Forecast Vaccine Type
  • 5.2. Attenuated Live Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.3. Conjugate Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.4. Inactivated Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.5. Dna Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.6. Recombinant Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.7. Other Vaccine Types Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL ANIMAL VACCINES MARKET: BY APPLICATION 2022-2034 (USD MN and Million Doses)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Bacterial Infections Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.3. Viral Infections Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.4. Parasitic Infections Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.5. Fungal Infections Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 7. GLOBAL ANIMAL VACCINES MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN and Million Doses)

  • 7.1. Market Analysis, Insights and Forecast Route Of Administration
  • 7.2. Injection Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 7.3. Oral Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 7.4. Immersion/Spray Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 8. GLOBAL ANIMAL VACCINES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN and Million Doses)

  • 8.1. Market Analysis, Insights and Forecast Distribution Channel
  • 8.2. Veterinary Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 8.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 8.4. E-Commerce Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 9. GLOBAL ANIMAL VACCINES MARKET: BY REGION 2022-2034 (USD MN and Million Doses)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 9.2.1 By Animal Type
    • 9.2.2 By Vaccine Type
    • 9.2.3 By Application
    • 9.2.4 By Route Of Administration
    • 9.2.5 By Distribution Channel
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 9.3.1 By Animal Type
    • 9.3.2 By Vaccine Type
    • 9.3.3 By Application
    • 9.3.4 By Route Of Administration
    • 9.3.5 By Distribution Channel
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 9.4.1 By Animal Type
    • 9.4.2 By Vaccine Type
    • 9.4.3 By Application
    • 9.4.4 By Route Of Administration
    • 9.4.5 By Distribution Channel
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 9.5.1 By Animal Type
    • 9.5.2 By Vaccine Type
    • 9.5.3 By Application
    • 9.5.4 By Route Of Administration
    • 9.5.5 By Distribution Channel
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 9.6.1 By Animal Type
    • 9.6.2 By Vaccine Type
    • 9.6.3 By Application
    • 9.6.4 By Route Of Administration
    • 9.6.5 By Distribution Channel
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL ANIMAL VACCINES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Zoetis
    • 11.2.2 Merck Animal Health
    • 11.2.3 Boehringer Ingelheim
    • 11.2.4 Elanco
    • 11.2.5 Virbac
    • 11.2.6 Ceva Sante Animale
    • 11.2.7 Dechra Pharmaceuticals
    • 11.2.8 Neogen Corporation
    • 11.2.9 Vetoquinol
    • 11.2.10 Brilliant Bio Pharma
    • 11.2.11 Indian Immunologicals
    • 11.2.12 Hipra
    • 11.2.13 Henry Schein
    • 11.2.14 Bioveta
    • 11.2.15 Durvet